These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 21621325

  • 1. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Tepaamorndech S, Huang L, Kirschke CP.
    Cancer Lett; 2011 Sep 01; 308(1):33-42. PubMed ID: 21621325
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.
    J Urol; 2005 May 01; 173(5):1778-83. PubMed ID: 15821586
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.
    Prostate; 2008 Oct 01; 68(14):1517-30. PubMed ID: 18668517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 9. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.
    Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639
    [Abstract] [Full Text] [Related]

  • 10. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM.
    Cancer Res; 1997 Aug 15; 57(16):3325-30. PubMed ID: 9269988
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M.
    Cancer Res; 2003 Sep 15; 63(18):5754-60. PubMed ID: 14522896
    [Abstract] [Full Text] [Related]

  • 12. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 13. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Yeh IT, Reddick RL, Kumar AP.
    Prostate; 2009 May 15; 69(7):755-60. PubMed ID: 19170049
    [Abstract] [Full Text] [Related]

  • 14. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
    Kela I, Harmelin A, Waks T, Orr-Urtreger A, Domany E, Eshhar Z.
    Prostate; 2009 Jul 01; 69(10):1034-44. PubMed ID: 19343735
    [Abstract] [Full Text] [Related]

  • 15. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A.
    Cancer Res; 2001 Sep 15; 61(18):6777-82. PubMed ID: 11559550
    [Abstract] [Full Text] [Related]

  • 16. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 17. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice.
    Fritz WA, Lin TM, Cardiff RD, Peterson RE.
    Carcinogenesis; 2007 Feb 15; 28(2):497-505. PubMed ID: 17052998
    [Abstract] [Full Text] [Related]

  • 18. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H, Gerald WL, Benezra R.
    Cancer Res; 2004 Sep 01; 64(17):6137-43. PubMed ID: 15342397
    [Abstract] [Full Text] [Related]

  • 19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.
    Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 accelerates multistep prostate carcinogenesis in vivo.
    Bruckheimer EM, Brisbay S, Johnson DJ, Gingrich JR, Greenberg N, McDonnell TJ.
    Oncogene; 2000 Nov 02; 19(46):5251-8. PubMed ID: 11077442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.